Publications | PubMed=7037175 Charles Patrick Reynolds, Debra A. Reynolds, Eugene Philip Frenkel, R. Graham Smith; Selective toxicity of 6-hydroxydopamine and ascorbate for human neuroblastoma in vitro: a model for clearing marrow prior to autologous transplant. Cancer Res. 42:1331-1336(1982) DOI=10.1016/B978-0-12-008304-6.50015-4 June Lee Biedler, Marian B. Meyers, Barbara A. Spengler; Homogeneously staining regions and double minute chromosomes, prevalent cytogenetic abnormalities of human neuroblastoma cells. (In book chapter) Advances in cellular neurobiology, Vol. 4; Fedoroff, Sergey & Hertz, Leif (eds.); pp.267-307; Academic Press; New York; USA (1983) PubMed=3456456; DOI=10.1093/jnci/76.3.375 Charles Patrick Reynolds, June Lee Biedler, Barbara A. Spengler, Debra A. Reynolds, Robert A. Ross, Eugene Philip Frenkel, R. Graham Smith; Characterization of human neuroblastoma cell lines established before and after therapy. J. Natl. Cancer Inst. 76:375-387(1986) DOI=10.1016/B978-0-12-333530-2.50006-X Mark A. Israel, Carol Jeanne Thiele; Tumor cell lines of the peripheral nervous system. (In book chapter) Atlas of human tumor cell lines; Hay, Robert J. & Park, Jae-Gahb & Gazdar, Adi F. (eds.); pp.43-78; Academic Press; New York; USA (1994) PubMed=8665486; DOI=10.1016/0304-3835(96)04250-4 Mitchell B. Diccianni, Lan S. Chau, Ayse Batova, Thai Q. Vu, Alice Lin-Tsing Yu; The p16 and p18 tumor suppressor genes in neuroblastoma: implications for drug resistance. Cancer Lett. 104:183-192(1996) DOI=10.1007/0-306-46872-7_2 Carol Jeanne Thiele; Neuroblastoma. (In book chapter) Human cell culture. Vol. 1. Cancer cell lines part 1; Masters, John R.W. & Palsson, Bernhard Orn (eds.); pp.21-53; Kluwer Academic Publishers; New York; USA (1999) PubMed=12702577 Fumiko Saito-Ohara, Issei Imoto, Jun Inoue, Hajime Hosoi, Akira Nakagawara, Tohru Sugimoto, Johji Inazawa; PPM1D is a potential target for 17q gain in neuroblastoma. Cancer Res. 63:1876-1883(2003) PubMed=15390183; DOI=10.1002/gcc.20096 Sigrun Gebauer, Alice Lin-Tsing Yu, Motoko Omura-Minamisawa, Ayse Batova, Mitchell B. Diccianni; Expression profiles and clinical relationships of ID2, CDKN1B, and CDKN2A in primary neuroblastoma. Genes Chromosomes Cancer 41:297-308(2004) PubMed=15720811; DOI=10.1593/neo.04310; PMCID=PMC1531688 Jeanette D. Walton, David R. Kattan, Sharon K. Thomas, Barbara A. Spengler, Hong-Fen Guo, June Lee Biedler, Nai-Kong V. Cheung, Robert A. Ross; Characteristics of stem cells from human neuroblastoma cell lines and in tumors. Neoplasia 6:838-845(2004) PubMed=15892104; DOI=10.1002/gcc.20198 Yael P. Mosse, Joel Greshock, Adam A. Margolin, Tara Naylor, Kristina A. Cole, Deepa Khazi, George Hii, Cynthia Winter, Syed Shahzad, Muhammad Usman Asziz, Jaclyn A. Biegel ...Show all 13 authors... , Barbara L. Weber, John Matthew Maris; Show fewer authors High-resolution detection and mapping of genomic DNA alterations in neuroblastoma. Genes Chromosomes Cancer 43:390-403(2005) PubMed=16822308; DOI=10.1186/1471-2407-6-177; PMCID=PMC1533846 Vincent Dam, Brian T. Morgan, Pavel Mazanek, Michael D. Hogarty; Mutations in PIK3CA are infrequent in neuroblastoma. BMC Cancer 6:177.1-177.10(2006) PubMed=24792489; DOI=10.1007/s11060-014-1456-8 Ahsan S. Farooqi, Rebecca A. Dagg, L. Mi Rim Choi, Jerry W. Shay, Charles Patrick Reynolds, Loretta M.S. Lau; Alternative lengthening of telomeres in neuroblastoma cell lines is associated with a lack of MYCN genomic amplification and with p53 pathway aberrations. J. Neurooncol. 119:17-26(2014) PubMed=28350380; DOI=10.1038/sdata.2017.33; PMCID=PMC5369315 Jo Lynne Harenza, Maura A. Diamond, Rebecca N. Adams, Michael M. Song, Heather L. Davidson, Lori S. Hart, Maiah H. Dent, Paolo Fortina, Charles Patrick Reynolds, John Matthew Maris; Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines. Sci. Data 4:170033.1-170033.8(2017) |